Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)

Alzheimer Disease Clinical Trial

— MMENSEA  

Official title:

Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03324711
• Other study ID #: 15/B/26
• Status: Terminated
• Phase: N/A
• Start date: November 15, 2016
• Est. completion date: July 2019

Study information

• Verified date: February 2022
• Source: University Hospital Center of Martinique
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main objective of the study is to analyze the psychometric properties of the "antillanisée" version of the Mini Mental State Examination (MMSEa). The methodology used will permit to explore the feasibility, acceptability, validity and reliability of the tool. The psychometric validation of a version adapted transculturally will increase the value of the results obtained with this test and will make it possible to refine the screening of existing cognitive disorders for elderly subjects with Alzheiner's disease or related disorders.

Description:

Patients will be recruited at the Geriatric Day Hospital. These patients came to a geriatric day hospital for examination without restriction on the reason for the hospitalization. They are referred by their general practitionner or referred by a specialist physician, live at home or in an institution and are representative of the geriatric population addressed by the MMSEa. - The main objective of the study is to analyze the psychometric properties of the "antillanisée" version of the Mini Mental State Examination (MMSEa). - The ancillary objective of this study will be to carry out the psychometric validation of the Short Physical Performance Battery (SPPB) in people aged 65 years or older. It is an instrument for measuring the physical performance of subjects whose transcultural adaptation and psychometric validation have already been performed in subjects aged 65 to 74 years. SPPB is used routinely in our routine practice in a day hospital, with no psychometric validation performed on this population. This ancillary objective will not modify the course of the MMSEa validation study since the SPPB is part of the evaluation tools.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 75
• Est. completion date: July 2019
• Est. primary completion date: April 11, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Subject of 65 years old and over
• Subject admitted in a geriatric day hospital
• Patients of creole culture
• Subject having French and/or Creole as mother tongue
• Subject able to undergo neuropsychological tests
• Subject having given informed consent or, informed consent given by his or her primary caregiver
• Subject affiliated to a social security scheme

Exclusion Criteria:

• Subject with a disability seriously compromising oral communication (understanding and expression)
• Subject with behavioral disorder that does not allow for testing
• Subject in general condition not allowing its participation in the tests
• Subject involved in another study including an exclusion period still in progress at the time of inclusion

Related Conditions & MeSH terms

• Alzheimer Disease
• Cognition Disorders
• Cognitive Disorder
• Elderly Patients

Intervention

Diagnostic Test:
• "Antillanisée" Mini Mental State Examination (MMSEa)
"Antillanisée" version of the Mini Mental State Examination (MMSEa), is a version adaptated to the French West Indies creole culture.

Locations

Country	Name	City	State
France	CHU de Martinique	Fort-de-France	Martinique

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Center of Martinique

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluation of the psychometric properties of the questionnaire MMSEa	The following will be measured: feasibility and acceptability; validity of structure; discriminant validity; predictive validity; validity of convergence; reliability (internal consistency,reproducibility (test-retest)).	12 month (+/- 15 days)
Secondary	Evaluation of the psychometric properties of questionnaire SPPB	The following will be measured: feasibility and acceptability; validity of structure; discriminant validity; predictive validity; reliability (internal consistency,reproducibility (test-retest)).	12 month (+/- 15 days)